-
6 November, 2026
New PRP treatment for persistent loss of smell at barnaclínic+
Loss of smell, or anosmia, is quite common after viral infections such as COVID-19. When it lasts more than a year and does not improve with conservative treatment, platelet-rich plasma (PRP) may be an option for recovering the sense of smell.
Many patients regain this sense spontaneously within weeks or months, but if there has been no change after a year, this is unlikely to happen. For these cases, barnaclínic+ offers PRP (platelet-rich plasma) treatment, which aims to stimulate regeneration of the olfactory system and support recovery of the sense of smell.
-
29 October, 2026
Teplizumab, a new treatment to delay the onset of type 1 diabetes, now available at barnaclínic+
barnaclínic+ now offers Teplizumab (Teizeild®), a new treatment for type 1 diabetes that can delay the onset of clinical diabetes in certain patients who have not yet developed symptoms. This new biological therapy represents a paradigm shift in the management of type 1 diabetes, as it makes it possible to target the autoimmune process responsible for destroying insulin-producing cells before treatment for clinical diabetes becomes necessary.
The introduction of Teplizumab expands the options for early treatment of type 1 diabetes at barnaclínic+ and highlights the importance of type 1 diabetes screening and early diagnosis. Identifying people in the early stages of the disease, before symptoms appear, makes it possible to assess new therapeutic options to delay its progression.
Teplizumab makes it possible to target the autoimmune process underlying type 1 diabetes and delay its progression to the clinical stage in eligible patients
-
28 October, 2026
Donanemab, a new treatment for Alzheimer’s disease now available at barnaclínic+
barnaclínic+ is expanding its treatment options for Alzheimer’s disease with donanemab (Kisunla®), a new treatment for patients in the early stages of the disease. This monoclonal antibody targets build-ups of beta-amyloid protein in the brain and has been shown to slow the progression of cognitive and functional decline in certain patients. The availability of donanemab in Barcelona marks a new step forward in the management of Alzheimer’s disease and underlines the importance of early diagnosis. This medicine belongs to a new generation of therapies which, unlike treatments that mainly focus on relieving symptoms, aim to act on one of the biological processes involved in the disease.
-
15 October, 2026
barnaclínic+ explores lumbar disc herniation and endoscopic spine surgery in the fifth episode of “Salud (t) Plus”
Following the previous episodes of “Salud (t) Plus”, the barnaclínic+ podcast that shares real health experiences through the voices of patients and professionals, this fifth episode focuses on lumbar disc herniation, a spinal condition that can cause lower back pain and leg pain, and on endoscopic spine surgery, a minimally invasive technique to treat it.
The episode features Àlex Moreno, who was injured while doing sport and lived for six months with pain that stopped him from leading a normal life, until he decided to have surgery. He is joined in the conversation by his partner, Esther Tacons, and Dr. Abel Ferrés, neurosurgeon at barnaclínic+.
-
8 October, 2026
barnaclínic+ explores refractive surgery with ICL lenses in the new episode of “Salud (t) Plus”
To mark World Sight Day, “Salud (t) Plus”, the barnaclínic+ podcast that shares real health experiences through the voices of patients and professionals, releases its fourth episode. This time it focuses on refractive surgery with ICL lenses, an alternative to laser surgery for correcting vision.
The episode features Josep Muñoz Irimia. Although refractive surgery is often thought of as a single solution for everyone, every case is different, and Josep’s was a special one: he had keratoconus in his left eye, a corneal condition that ruled out laser surgery. He is joined in the conversation by his father, Antonio Muñoz; Dr. Josep Torras, ophthalmologist specialising in cornea and refractive surgery at visiõnclínic; and Patricia Martín, optometrist specialising in refractive surgery at visiõnclínic.
-
25 September, 2026
Facial resurfacing surgery at barnaclínic+: new options to regain movement and your smile
The introduction of advanced surgical techniques expands treatment options for patients with permanent facial paralysis or persistent effects affecting their smile, eye closure and other facial movements
barnaclínic+ is strengthening its specialist approach to facial paralysis with new options for facial paralysis surgery and facial reanimation, integrated into a multidisciplinary model that supports patients from assessment and rehabilitation through to surgical treatment when indicated.
-
25 September, 2026
barnaclínic+ introduces Omnipod 5, a new tubeless closed-loop system
barnaclínic+ introduces Omnipod 5 ®, a new automated insulin delivery system for people with type 1 diabetes that offers a key difference compared with other insulin pumps: it does not require tubing or an external catheter. The system uses a small Pod that adheres directly to the skin and automatically delivers insulin based on glucose readings obtained from a continuous glucose monitoring sensor.
With the introduction of Omnipod 5, barnaclínic+ expands the range of options available within its closed-loop systems or artificial pancreas systems for type 1 diabetes, which include different automated insulin delivery technologies. The aim is to select the most appropriate option for each person, taking into account both their clinical needs and their preferences and lifestyle.
The new automated insulin pump is worn directly on the body and eliminates the tubing and external catheter used in traditional infusion systems
-
24 September, 2026
barnaclínic+ Rehabilitation expands with new services and state-of-the-art facilities
Physical Medicine and Rehabilitation at barnaclínic+ is entering a new phase with a broader range of healthcare services and new facilities specifically dedicated to rehabilitation, physiotherapy and functional recovery. Led by Dr Conxita Closa, a specialist in Physical Medicine and Rehabilitation and Head of the Rehabilitation Department at Hospital Clínic Barcelona, the new model combines clinical excellence, personalised care, advanced technology and state-of-the-art facilities to address problems affecting mobility, function and independence.
Services are provided at Epsilon Physio Sports Medical Center, located in central Barcelona, with barnaclínic+ as its medical partner. Its 1,200 m² facilities include spaces for individualised treatments and a large functional recovery area, allowing patients to receive continuous care from medical assessment and diagnosis through to physiotherapy, therapeutic exercise and the different stages of their recovery.
-
2 September, 2026
barnaclínic+ strengthens heart failure care with a specialised Unit
barnaclínic+ strengthens its specialised Cardiology services with the consolidation of a dedicated Heart Failure Unit, bringing together and enhancing the expertise, specialists and resources available for the diagnosis, treatment and follow-up of patients with heart failure. The Unit is staffed by cardiologists from Hospital Clínic de Barcelona with specific expertise in this condition, providing coordinated care throughout every stage of the disease, from diagnosis and early treatment optimisation to the management of advanced heart failure.
This model of care is based on personalised medicine, multidisciplinary collaboration and specialist follow-up, with access to highly accurate diagnostic techniques, innovative drug therapies, interventional procedures and advanced treatments.
-
2 September, 2026
barnaclínic+ launches its new Podiatry Unit for the comprehensive diagnosis and treatment of foot conditions
The feet are the foundation of our musculoskeletal system. They support our body weight, absorb the impact of every step and play a fundamental role in mobility and quality of life. However, many people live for years with foot pain, gait abnormalities or conditions such as ingrown toenails, fungal nail infections, plantar warts, bunions or plantar fasciitis without consulting a specialist. To provide comprehensive, specialised care, barnaclínic+ has launched its new Podiatry Unit in Barcelona, a dedicated service focused on the prevention, diagnosis and treatment of foot conditions and disorders.
A specialised team dedicated to preventing, diagnosing and treating the most common foot conditions, improving gait and helping people walk without pain
